These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 9260776)

  • 21. Insulin allergy; desensitization with crystalline zinc-insulin and steroid tapering.
    Yokoyama H; Fukumoto S; Koyama H; Emoto M; Kitagawa Y; Nishizawa Y
    Diabetes Res Clin Pract; 2003 Sep; 61(3):161-6. PubMed ID: 12965105
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Type III Hypersensitivity Reaction to Subcutaneous Insulin Preparations in a Type 1 Diabetic.
    Murray BR; Jewell JR; Jackson KJ; Agboola O; Alexander BR; Sharma P
    J Gen Intern Med; 2017 Jul; 32(7):841-845. PubMed ID: 28337685
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intradermal desensitization with human insulin (recombinant DNA) in a patient with severe allergic skin reaction due to insulin.
    Bachmann W; Hasche H; Mehnert H
    Diabetes Care; 1982; 5 Suppl 2():165-7. PubMed ID: 6765529
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A practical, clinical approach to the assessment and management of suspected insulin allergy.
    Jacquier J; Chik CL; Senior PA
    Diabet Med; 2013 Aug; 30(8):977-85. PubMed ID: 23601039
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Delayed hypersensitivity to protamine and immediate hypersensitivity to insulin].
    Köllner A; Senff H; Engelmann L; Kalveram KJ; Velcovsky HG; Haneke E
    Dtsch Med Wochenschr; 1991 Aug; 116(33):1234-8. PubMed ID: 1831420
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Treatment of allergy to heterologous monocomponent insulin with human semisynthetic insulin. Long-term study.
    Bruni B; Barolo P; Blatto A; Carlini M; Ansaldi SG; Grassi G
    Diabetes Care; 1988 Jan; 11(1):59-62. PubMed ID: 3276478
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long-term benefits of continuous subcutaneous insulin infusion in children with Type 1 diabetes: a 4-year follow-up.
    Sulli N; Shashaj B
    Diabet Med; 2006 Aug; 23(8):900-6. PubMed ID: 16911629
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Development of insulin allergy after bone marrow transplantation.
    Yoshida N; Okubo M; Ishiguro K; Mori Y
    Diabet Med; 2012 Oct; 29(10):1339-41. PubMed ID: 22587424
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Continuous subcutaneous insulin infusion versus multiple daily injections of insulin: economic comparison in adult and adolescent type 1 diabetes mellitus in Australia.
    Cohen N; Minshall ME; Sharon-Nash L; Zakrzewska K; Valentine WJ; Palmer AJ
    Pharmacoeconomics; 2007; 25(10):881-97. PubMed ID: 17887808
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Heparin allergy: delayed-type non-IgE-mediated allergic hypersensitivity to subcutaneous heparin injection.
    Trautmann A; Seitz CS
    Immunol Allergy Clin North Am; 2009 Aug; 29(3):469-80. PubMed ID: 19563992
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A case of insulin allergy: the crystalline human insulin may mask its antigenicity.
    Takatsuki H; Ishii H; Yamauchi T; Nakashima N; Nagase S; Hisatomi A; Umeda F; Nawata H
    Diabetes Res Clin Pract; 1991 May; 12(2):137-9. PubMed ID: 1879305
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Desensitization of allergy to human insulin and its analogs by administering insulin aspart and insulin glargine.
    Wu P; Ji C; Wang M; Zou S; Ge W
    Ann Endocrinol (Paris); 2013 Feb; 74(1):56-8. PubMed ID: 23351561
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Long-acting insulin allergy in a diabetic child.
    Mastrorilli C; Rizzuti L; Cangelosi AM; Iovane B; Chiari G; Caffarelli C
    Int J Immunopathol Pharmacol; 2017 Jun; 30(2):174-177. PubMed ID: 28368217
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Insulin allergy: clinical manifestations and management strategies.
    Heinzerling L; Raile K; Rochlitz H; Zuberbier T; Worm M
    Allergy; 2008 Feb; 63(2):148-55. PubMed ID: 18186805
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Immediate type allergy to insulin (author's transl)].
    Velcovsky HG; Beringhoff B; Federlin K
    Immun Infekt; 1978 Aug; 6(4):146-52. PubMed ID: 150399
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fields of application of continuous subcutaneous insulin infusion in the treatment of diabetes and implications in the use of rapid-acting insulin analogues.
    Pitocco D; Rizzi A; Scavone G; Tanese L; Zaccardi F; Manto A; Ghirlanda G
    Minerva Endocrinol; 2013 Sep; 38(3):321-8. PubMed ID: 24126552
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A case of newly diagnosed non-insulin-dependent diabetes associated with immediate-type allergy against human insulin.
    Yamagishi S; Abe T; Sawada T
    Horm Res; 1995; 43(6):300-2. PubMed ID: 7607616
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Continuous intraperitoneal insulin infusion partly restores the glucagon response to hypoglycaemia in type 1 diabetic patients.
    Oskarsson PR; Lins PE; Backman L; Adamson UC
    Diabetes Metab; 2000 Apr; 26(2):118-24. PubMed ID: 10804326
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Allergy reactions to insulin: effects of continuous subcutaneous insulin infusion and insulin analogues.
    Radermecker RP; Scheen AJ
    Diabetes Metab Res Rev; 2007 Jul; 23(5):348-55. PubMed ID: 17216593
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Substitution of night-time continuous subcutaneous insulin infusion therapy for bedtime NPH insulin in a multiple injection regimen improves counterregulatory hormonal responses and warning symptoms of hypoglycaemia in IDDM.
    Kanc K; Janssen MM; Keulen ET; Jacobs MA; Popp-Snijders C; Snoek FJ; Heine RJ
    Diabetologia; 1998 Mar; 41(3):322-9. PubMed ID: 9541173
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.